Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 6.5K | $250K | $38.49 | Apr 25, 2024 | Direct |
HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
CHINOOK THERAPEUTICS, INC. | Director | Common Stock | 0 | $39.03 | Aug 11, 2023 | Direct | |
CHINOOK THERAPEUTICS, INC. | Director | Restricted Stock Units | 0 | Aug 11, 2023 | Direct | ||
CHINOOK THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 0 | $26.12 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 0 | $0 | 3 | Apr 25, 2024 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Aug 11, 2023 | 3 | -$619K | 4 | Aug 11, 2023 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Apr 1, 2023 | 3 | -$21.3K | 4 | Apr 4, 2023 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Apr 2, 2022 | 2 | $0 | 4 | Apr 5, 2022 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Mar 18, 2022 | 0 | $0 | 3 | Mar 29, 2022 | Director |